Hey tele, you MIGHT want to read behind the lead/link in

New Post Public Reply Private Reply Replies (2) Message Board
Bhawks copytele #117765
347
Hey tele, you MIGHT want to read behind the lead/link in your bat shit, junk science, laden posts. Just sayin'. This one is truly embarrassing.


The Strange Case of Dr. Cahill and Ms. Hyde

Professor Dolores Cahill’s scientific résumé can legitimize her false claims about COVID-19. Her crusade of misinformation raises the question of how far academic freedom goes.



https://www.mcgill.ca/oss/article/covid-19-he...nd-ms-hyde

Cahill, who until recently was teaching a class for first-year medical students called “Science, Medicine and Society,” has been making a number of staggeringly erroneous claims about COVID-19 and its associated vaccines since the beginning of the pandemic, never correcting her mistakes and always doubling down.

She has said, falsely, that COVID-19 can be prevented by taking vitamin C, vitamin D and zinc, and that the most efficient treatment is in the form of hydroxychloroquine, a cheap medication against malaria and autoimmune diseases that turned into an object of worship for some individuals, even as the evidence clearly showed it did not work against COVID-19.

She has boldly stated that children wearing a mask—the kind that doctors, nurses and dentists have been wearing for decades—would be starved of oxygen and see their IQ lowered.

As for the RNA-based vaccines, she falsely claimed they did more harm than good. “If you paid me ten million,” she warned, “I wouldn’t take it. I would go to prison first. If someone vaccinated me [with an RNA vaccine], I would charge them with attempted murder.”

Bolstered by Cahill’s academic and scientific credentials, her misinformed and hazardous claims have grown to the point where students at her university wrote a 33-page scientific rebuttal of these claims, a document that was signed by 133 students from the university’s own School of Medicine and sent to its administrators.

One of the claims these students had to debunk: that once you get COVID-19, you are immune for life. This brazen assertion’s confidence is in contradiction with actual knowledge in the field, which is that we do not clearly know how long immunity does last. But this is the upside-down world at University College Dublin right now, where students are teaching their own professor basic facts about a topic she should be familiar with.

Because Dolores Cahill is not a naturopath, or a multilevel marketing supplement saleswoman, or a bestselling author claiming that a spirit whispers medical information from the future into her ear. She has a proper biomedical research background, working for many years at the Max Planck Institute of Molecular Genetics and as an advisor and international expert on many boards and committees, including the Irish Government’s Advisory Science Council. Ironically, she has also been active in the field of scientific integrity.

To say that her credentials are at odds with her public campaign of COVID denialism is to put it mildly: her pre- and post-pandemic academic selves seem completely at odds with each other. When, arguing against physical distancing, she claimed that “only three organisms are transmitted in that way [via the air]: it’s tuberculosis and smallpox and Ebola,” I’m at a loss for words. Has she never heard of measles? Does she not know that hospitalized patients with the flu are isolated to prevent transmission? Does she understand respiratory infections?

While the School of Medicine eventually distanced itself from her views on COVID-19, the university cited strict guidelines on academic freedom as a reason for their inaction. Can university professors say whatever they want, no matter the harm they cause, and get away with it?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Multiconsult-Rejlers Merger Revs Up Nordic Market Power

Updated Category News Views 2

A New Powerhouse in the Nordic Consultancy Space September 7, 2026, will likely be etched into the annals of stock market moves, marking the day two titans, Multiconsult and Rejlers, decided to tie the knot. This isn't your average merger. We're talking about a calculated Pan-Nordic push that's been building, and now, well, it's paying off with a potential powerhouse of...

Continue Reading
Hims & Hers Health Hit by FTC Claims and Class Action

Updated Category News Views 0

Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...

Continue Reading
Navimow Powers TOP 14 with Tech: A Winning Play

Updated Category News Views 4

A Technological Leap for French Rugby Innovation and precision in partnerships—those words don't usually pop up together when chatting about a rugby league. But here we are, discussing the TOP 14, the elite French rugby championship, pairing up with Segway Navimow. This brand, under the umbrella of Ninebot Limited (689009.SH), is stepping into the world of sports for...

Continue Reading
GBC 2026 Wraps Up: Korea Eyes Bio Industry Leadership

Updated Category News Views 2

GBC 2026: Korea's Giant Leap in Bio Innovation Well, there wasn't a dull moment at the 'Global Bio Conference 2026' in Seoul. Picture a melting pot where 5,600 participants from 19 countries converged to chat about the latest and greatest in biopharma innovation and regulatory strategies. That's not a setup you see every day, mind you. This event packed the room with...

Continue Reading
DoorDash Speeds Up Gifting: Same-Day Delivery Wins

Updated Category News Views 0

Transforming Urgent Gift-Giving with Local Delivery Ever found yourself scrambling for a last-minute gift when time seems to be slipping away? That's where DoorDash steps up, changing the game with their same-day delivery options. In the fast-paced world we're living in, folks aren't just leaning on DoorDash for takeout anymore. They're pushing it as a lifeline for...

Continue Reading
UST Grabs Italdesign: Driving Future Mobility with AI

Updated Category News Views 3

UST's Strategic Move Into Automotive's Future Wake up and smell the coffee, because UST is shaking up the automotive scene. They've just pulled off a major play by grabbing a majority stake in Italdesign. If that doesn't scream the next leap forward for the auto world, I don't know what does. UST isn't just buying a company; it's marrying Italdesign's legendary design...

Continue Reading
Nuix Leverages AI for Transformative Legal Review

Updated Category News Views 1

Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...

Continue Reading
VEVOR Unveils New Products at IFA Berlin 2026

Updated Category News Views 1

VEVOR's Bold Display at IFA Berlin VEVOR isn't shy about making waves at IFA Berlin 2026. The global home improvement heavyweight decided to go all out with an interactive booth that's hard to miss, giving visitors a real taste—sometimes literally—of what they’ve got to offer. This hands-on approach isn't just a gimmick; it’s a clever move to solidify VEVOR's...

Continue Reading
Huayan Robotics Hits IMTS 2026 with Cutting-Edge Tech

Updated Category News Views 1

Unveiling Robotics Prowess at IMTS 2026 Every two years, the world of manufacturing gathers at the International Manufacturing Technology Show (IMTS), and this time, the spotlight is on Huayan Robotics. With the event drawing over 90,000 professionals, everybody with a finger on the pulse of intelligent manufacturing will be keen to see what Huayan has up its sleeve. This...

Continue Reading

Top 5 Most Recently Viewed Articles

CEO Confidence: Understanding Dolphin Entertainment's Stock Moves

Updated Category News Views 114

CEO Insights: Motivation Behind Stock Accumulation In the world of investing, the actions of company insiders often speak louder than words. While public statements and press releases paint a picture, nothing quite conveys confidence like a CEO investing their own money into their company's stock. This trend is particularly evident at Dolphin Entertainment, where CEO...

Continue Reading
Insights on AR/VR Market Growth and Competitive Landscape

Updated Category News Views 130

Meta's Dominating Role in the AR/VR Market According to recent data, global shipments of AR/VR headsets have seen a remarkable rebound, marking a significant growth of 12.8%. After facing declines for two consecutive quarters, the industry is witnessing an upswing that can largely be attributed to the innovations and market strategies of a leading player: Meta. Market...

Continue Reading
Investigation into Fortinet, Inc.: Shareholder Concerns Rise

Updated Category News Views 263

Overview of the Investigation into Fortinet, Inc. Pomerantz LLP is currently conducting an investigation into Fortinet, Inc. (NASDAQ: FTNT), focusing on potential claims by investors. This inquiry aims to uncover any alleged involvement of the company's officers or directors in securities fraud or other unlawful business practices that may affect shareholder interests....

Continue Reading
Umicore Reports Key Shareholding Changes from Bank of America

Updated Category News Views 252

Notification from Bank of America Corporation to Umicore Umicore has received a transparency notification from Bank of America Corporation that highlights a critical change in their shareholding structure. This notification, dictated by legal obligations regarding significant ownership stakes, reveals that Bank of America has surpassed the 3% threshold in its direct...

Continue Reading
Aalberts N.V. Posts Q3 2025 Financial Results and Outlook

Updated Category News Views 330

Aalberts N.V. Financial Overview for Third Quarter 2025 Aalberts N.V. has reported its financial results for the third quarter of 2025, showcasing a total revenue of EUR 772.5 million. This reflects a 1.9% organic revenue decline compared to the same period last year. The company also achieved an EBITA of EUR 96.3 million, which corresponds to a margin of 12.5%. Market...

Continue Reading